Celularity, Inc. (GXGX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1249771,
    "name": "Celularity, Inc.",
    "stock_name": "Celularity, Inc.",
    "full_name": "Celularity, Inc.",
    "name_url": "stocks-analysis/celularity-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.97",
    "chg": -0.05,
    "chgp": "-2.33%",
    "dir": -1,
    "prev_price": "2.02",
    "mcapval": "56.32",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "US1511901050",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "92.37 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/celularity-inc-1249771-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Celularity, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celularity-inc-forms-death-cross-signaling-potential-bearish-trend-ahead-3726003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CelularityInc_dealthcross_3726003.png",
        "date": "2025-11-24 15:17:05",
        "description": "Celularity, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. Current technical indicators suggest a bearish outlook, despite a brief performance uptick. The company's longer-term performance remains troubling, with significant declines over the past year and five years compared to the S&P 500."
      },
      {
        "title": "Celularity, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/celularity-inc-forms-death-cross-signaling-potential-bearish-trend-ahead-3690282",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CelularityInc_dealthcross_3690282.png",
        "date": "2025-11-11 16:08:33",
        "description": "Celularity, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. Technical indicators suggest a bearish outlook, with significant declines in performance over the past year and negative earnings reflected in its PE ratio. This situation may heighten investor scrutiny regarding the company's future."
      },
      {
        "title": "Is Celularity, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-celularity-inc-technically-bullish-or-bearish-3548343",
        "imagepath": "",
        "date": "2025-09-20 20:15:21",
        "description": "As of 2 September 2025, the technical trend for Celularity, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, suggesting some short-term strength. However, the Bollinger Bands are bearish on both weekly and monthly time frames, which is a negative indicator. The KST and OBV are both mildly bullish on a monthly basis, providing some support to the overall stance. \n\nIn terms of performance, Celularity has underperformed the S&P 500 across multiple periods, with a significant decline of 89.67% over the past three years compared to a 70.41% gain in the S&P 500. Overall, the current technical stance is mildly bullish, but the strength is tempered by bearish signals in the Bollinger Bands and mixed MACD readings...."
      },
      {
        "title": "Is Celularity, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-celularity-inc-overvalued-or-undervalued-3544402",
        "imagepath": "",
        "date": "2025-09-20 18:45:22",
        "description": "As of 14 August 2023, the valuation grade for Celularity, Inc. has moved from attractive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 5.64 and an EV to Sales ratio of 1.69, which suggest a premium valuation despite significant operational losses reflected in its negative P/E and ROE of -612.01%. \n\nIn comparison to its peers, Celularity's valuation ratios are concerning; for instance, PaySign, Inc. has a P/E of 42.86, while FONAR Corp. shows a fair valuation with a P/E of 8.99. The stark contrast in these ratios highlights Celularity's relative overvaluation in a challenging industry. Additionally, the company's recent stock performance has been poor, with a 1-month return of -47.23% compared to the S&P 500's 2.33%, reinforcing the notion that the stock is struggling signif..."
      }
    ],
    "total": 8,
    "sid": "1249771",
    "stock_news_url": "https://www.marketsmojo.com/news/celularity-inc-1249771"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Celularity, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead

2025-11-24 15:17:05

Celularity, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. Current technical indicators suggest a bearish outlook, despite a brief performance uptick. The company's longer-term performance remains troubling, with significant declines over the past year and five years compared to the S&P 500.

Celularity, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead

2025-11-11 16:08:33

Celularity, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. Technical indicators suggest a bearish outlook, with significant declines in performance over the past year and negative earnings reflected in its PE ratio. This situation may heighten investor scrutiny regarding the company's future.

Is Celularity, Inc. technically bullish or bearish?

2025-09-20 20:15:21

As of 2 September 2025, the technical trend for Celularity, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, suggesting some short-term strength. However, the Bollinger Bands are bearish on both weekly and monthly time frames, which is a negative indicator. The KST and OBV are both mildly bullish on a monthly basis, providing some support to the overall stance. In terms of performance, Celularity has underperformed the S&P 500 across multiple periods, with a significant decline of 89.67% over the past three years compared to a 70.41% gain in the S&P 500. Overall, the current technical stance is mildly bullish, but the strength is tempered by bearish signals in the Bollinger Bands and mixed MACD readings....

Is Celularity, Inc. overvalued or undervalued?

2025-09-20 18:45:22

As of 14 August 2023, the valuation grade for Celularity, Inc. has moved from attractive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 5.64 and an EV to Sales ratio of 1.69, which suggest a premium valuation despite significant operational losses reflected in its negative P/E and ROE of -612.01%. In comparison to its peers, Celularity's valuation ratios are concerning; for instance, PaySign, Inc. has a P/E of 42.86, while FONAR Corp. shows a fair valuation with a P/E of 8.99. The stark contrast in these ratios highlights Celularity's relative overvaluation in a challenging industry. Additionally, the company's recent stock performance has been poor, with a 1-month return of -47.23% compared to the S&P 500's 2.33%, reinforcing the notion that the stock is struggling signif...

View All News